BCM
TEVA icon

Barometer Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Barometer Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Buy
+77,800
New +$2.5M 0.8% 30
2025
Q3 		– Sell
-19,700
Closed -$330K – 207
2025
Q2 		$330K Buy
19,700
+6,800
+53% +$110K 0.09% 121
2025
Q1 		$198K Buy
12,900
+2,800
+28% +$50K 0.07% 115
2024
Q4 		$223K Buy
10,100
+700
+7% +$12.7K 0.09% 98
2024
Q3 		$169K Buy
+9,400
New +$165K 0.05% 129

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barometer Capital Management's TEVA Position: Q1 2026 in Review

Barometer Capital Management opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 77,800 shares worth $2.34M. The stake represents 0.8% of the portfolio and ranks #30 among its holdings. This is a return to the name: Barometer Capital Management previously reported a position in TEVA as recently as Q2 2025.

Barometer Capital Management first reported a position in TEVA in Q3 2024 and has held it in 5 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Barometer Capital Management held 77,800 shares of Teva Pharmaceuticals worth $2.34M as of Q1 2026.
  • Teva Pharmaceuticals was a new Barometer Capital Management position in Q1 2026.
  • Teva Pharmaceuticals made up 0.8% of Barometer Capital Management's portfolio in Q1 2026, its #30 holding.
  • Barometer Capital Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Barometer Capital Management's 13F filing for Q1 2026, filed 12 May 2026.